Prefrontal D1 signaling and cognitive symptoms of Parkinson's disease
帕金森病的前额叶 D1 信号传导和认知症状
基本信息
- 批准号:8792297
- 负责人:
- 金额:$ 28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-15 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAgingAnimal ModelAreaAttentionAttention deficit hyperactivity disorderAutomobile DrivingBehaviorBrainBrain regionCerebral cortexCessation of lifeCognitionCognitiveCognitive deficitsCorpus striatum structureDataDevelopmentDiseaseDopamineDopamine D1 ReceptorDopamine ReceptorDorsalEmploymentGeneticGoalsHuntington DiseaseImpaired cognitionInfusion proceduresKnowledgeLeadLinkMalignant - descriptorMapsModelingMorbidity - disease rateMusNeurobehavioral ManifestationsNeuronsNursing HomesParkinson DiseasePatientsPatternPharmaceutical PreparationsPrefrontal CortexProcessPublic HealthPyramidal CellsRampRodentRoleSchizophreniaShort-Term MemorySignal TransductionSocietiesStimulusSystemTechniquesTimeTransgenic MiceVentral Tegmental AreaWorkaddictioncognitive controlcostdopaminergic neuroneffective therapyhippocampal pyramidal neuronimprovedinsightmortalityneural circuitoptogeneticspublic health relevancereceptorrelating to nervous systemresearch studytime interval
项目摘要
DESCRIPTION (provided by applicant): Cognitive symptoms of Parkinson's disease are emerging as an enormous public health problem. Up to 80% of PD patients will suffer debilitating cognitive symptoms in the course of their disease. In PD patients, cognitive impairments predict a malignant disease course leading to loss of employment, independence, driving deficits, nursing home placement, and death. Because PD is strongly associated with aging, this problem will surge as our society ages. There are few treatments that improve PD-related cognitive symptoms. Thus there is a critical need to develop new, mechanistic treatments for cognitive symptoms of PD. A challenge in developing new treatments is that there is a knowledge gap about the mechanism of PD-related cognitive symptoms. Cognitive deficits in PD patients include impaired working memory, attention, reasoning, planning, and timing. One elementary cognitive task in which PD patients are reliably impaired is interval timing. In this task, subjects are presented with a stimulus, and estimate its duration over several seconds. Interval timing is an ideal window into cognition in PD because this task depends on dopamine and can be readily studied in animal models. Elucidating the neural circuitry of interval timing could help close the knowledge gap about cognitive dysfunction in PD. Our preliminary data strongly implicate D1-type dopamine receptors on pyramidal neurons in the prefrontal area of the cerebral cortex in interval timing. However, it is unclear precisely how
prefrontal neurons influence interval timing. Here we combine highly selective and specific techniques such as optogenetics, focal drug infusions, and neuronal ensemble recordings to systematically interrogate the neural activity of prefrontal D1 neurons in great detail, and to map
the projections of these neurons. In Aim 1, we determine how prefrontal D1 neurons control interval timing. In Aim 2, we determine which projections of prefrontal D1 neurons control interval timing. Finally, in Aim 3 we rescue interval timing deficits in animal models of PD by stimulating prefrontal D1 neurons and their projections. This work will identify key drivers of a cognitive process impaired in PD patients. Our findings could link a brain region and a receptor system to cognitive processes impaired in PD, and could spur development of targeted pharmacological, genetic, or brain-stimulation therapies. Insights from this work could have relevance for PD as well as for other diseases involving prefrontal dopamine circuits, such as schizophrenia, ADHD, addiction, and Huntington's disease.
描述(由申请人提供):帕金森病的认知症状正在成为一个巨大的公共卫生问题。高达80%的PD患者在发病过程中会出现认知功能衰弱的症状。在PD患者中,认知障碍预示着恶性病程,导致失业、独立、驾驶缺陷、养老院安置和死亡。因为帕金森病与衰老密切相关,这个问题将随着我们社会的老龄化而激增。很少有治疗方法可以改善pd相关的认知症状。因此,迫切需要开发新的机制治疗PD的认知症状。开发新疗法的一个挑战是,关于pd相关认知症状的机制存在知识缺口。PD患者的认知缺陷包括工作记忆、注意力、推理、计划和时机受损。PD患者的一个基本认知任务是间隔时间。在这项任务中,受试者被呈现一个刺激,并在几秒钟内估计其持续时间。间隔时间是研究帕金森病认知的理想窗口,因为这一任务依赖于多巴胺,可以在动物模型中很容易地进行研究。阐明间隔时间的神经回路有助于缩小PD认知功能障碍的知识空白。我们的初步数据强烈暗示d1型多巴胺受体在间隔时间大脑皮层前额叶区锥体神经元。然而,目前还不清楚具体是如何做到的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nandakumar Narayanan其他文献
Nandakumar Narayanan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nandakumar Narayanan', 18)}}的其他基金
VTA dopamine neurons and cognitive symptoms of Parkinson’s disease
VTA 多巴胺神经元和帕金森病的认知症状
- 批准号:
10176823 - 财政年份:2021
- 资助金额:
$ 28万 - 项目类别:
VTA dopamine neurons and cognitive symptoms of Parkinson’s disease
VTA 多巴胺神经元和帕金森病的认知症状
- 批准号:
10361526 - 财政年份:2021
- 资助金额:
$ 28万 - 项目类别:
The Administrative Core of Prefrontal Cortex, Cognition, and Speech Symptoms in Parkinson’s disease (PRECIS-PD)
帕金森病的前额皮质、认知和言语症状的管理核心 (PRECIS-PD)
- 批准号:
10283242 - 财政年份:2021
- 资助金额:
$ 28万 - 项目类别:
VTA dopamine neurons and cognitive symptoms of Parkinson’s disease
VTA 多巴胺神经元和帕金森病的认知症状
- 批准号:
10586138 - 财政年份:2021
- 资助金额:
$ 28万 - 项目类别:
Prefrontal Cortex, Cognition, and Speech Symptoms in PD (PRECIS-PD)
PD 中的前额皮质、认知和言语症状 (PRECIS-PD)
- 批准号:
10490434 - 财政年份:2021
- 资助金额:
$ 28万 - 项目类别:
The Administrative Core of Prefrontal Cortex, Cognition, and Speech Symptoms in Parkinson’s disease (PRECIS-PD)
帕金森病的前额皮质、认知和言语症状的管理核心 (PRECIS-PD)
- 批准号:
10490435 - 财政年份:2021
- 资助金额:
$ 28万 - 项目类别:
Prefrontal Cortex, Cognition, and Speech Symptoms in PD (PRECIS-PD)
PD 中的前额皮质、认知和言语症状 (PRECIS-PD)
- 批准号:
10283241 - 财政年份:2021
- 资助金额:
$ 28万 - 项目类别:
Mid-frontal delta/theta rhythms and cognitive control in PD
PD 中额叶 delta/theta 节律和认知控制
- 批准号:
10187663 - 财政年份:2017
- 资助金额:
$ 28万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Operating Grants














{{item.name}}会员




